US Patent Issued to Celgene on June 16 for "Formulations of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione" (New Jersey Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. RE50,917, issued on June 16, was assigned to Celgene Corp. (Summit, N.J.).

"Formulations of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione" was invented by Darshan Parikh (Bridgewater, N.J.) and Anil Menon (Martinsville, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions and single unit dosage forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione, or a pharmaceutically acceptable stereoisomer, prodrug, salt, solvate, hydrate, or clathrate, are provided herein. Also provided are methods of treating, managing, or preventing various disorders, such as ca...